tobramycin has been researched along with Cochlear Hearing Loss in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anniko, M; Asplund, MS; Lidian, A; Linder, B; Takumida, M | 1 |
Smyth, AR | 1 |
Cheung, PY; Etches, PC; Peliowski, A; Robertson, CM; Tyebkhan, JM | 1 |
Patatanian, L | 1 |
Antonelli, M; Crifo, S; Gagliardi, M; Lucarelli, N; Marcolini, P | 1 |
Papapella, MM; Schachern, PA; Sone, M; Zheng, Y | 1 |
Hinojosa, R; Lerner, SA; Nelson, EG; Redleaf, MI; Schramm, DR | 1 |
Abramson, AL; Forman-Franco, B; Gorvoy, JD; Stein, T | 1 |
Jensen, T; Osterhammel, D; Osterhammel, P; Pedersen, SS | 1 |
1 trial(s) available for tobramycin and Cochlear Hearing Loss
Article | Year |
---|---|
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
Topics: Amikacin; Aminoglycosides; Anti-Infective Agents; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Ethacrynic Acid; Female; Furosemide; Gentamicins; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Male; Pancuronium; Respiratory Insufficiency; Severity of Illness Index; Tobramycin; Vancomycin; Vecuronium Bromide | 2006 |
8 other study(ies) available for tobramycin and Cochlear Hearing Loss
Article | Year |
---|---|
Protective effect of edaravone against tobramycin-induced ototoxicity.
Topics: Animals; Anti-Bacterial Agents; Antipyrine; Drug Administration Schedule; Edaravone; Evoked Potentials, Auditory, Brain Stem; Free Radical Scavengers; Hearing Loss, Central; Hearing Loss, Sensorineural; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tobramycin | 2009 |
Minimizing the toxicity of aminoglycosides in cystic fibrosis.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Bacterial Agents; Chronic Disease; Cystic Fibrosis; DNA, Mitochondrial; Drug Administration Schedule; Genetic Predisposition to Disease; Gentamicins; Hearing Loss, Sensorineural; Humans; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Insufficiency; Tobramycin | 2010 |
Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Cystic Fibrosis; Hearing Loss, Sensorineural; Humans; Male; Renal Insufficiency; Tobramycin | 2006 |
Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Gentamicins; Hearing Loss; Hearing Loss, Conductive; Hearing Loss, Sensorineural; Humans; Long-Term Care; Tobramycin | 1980 |
Aminoglycoside ototoxicity.
Topics: Adult; Anti-Bacterial Agents; Audiometry, Pure-Tone; Cystic Fibrosis; Fatal Outcome; Female; Hearing Loss, Sensorineural; Humans; Organ of Corti; Tobramycin | 2001 |
Aminoglycoside ototoxicity: a human temporal bone study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Cell Death; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Gentamicins; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Male; Spiral Ganglion; Tobramycin | 2001 |
Cystic fibrosis and hearing loss.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Audiometry; Auditory Threshold; Child; Cystic Fibrosis; Ear Ossicles; Ear, Middle; Female; Gentamicins; Hearing Loss; Hearing Loss, Conductive; Hearing Loss, Sensorineural; Humans; Male; Pressure; Stapes; Tobramycin; Tympanic Membrane | 1979 |
Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Hearing Loss, Sensorineural; Humans; Kidney Diseases; Labyrinth Diseases; Male; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1987 |